Search for: "Mark Herrmann"
Results 541 - 560
of 675
Sort by Relevance
|
Sort by Date
27 Jan 2009, 9:00 pm
See Mark Herrmann, "Class Actions: Are you a class member? [read post]
26 Jan 2009, 5:56 am
With two accomplices, Drug and Device Blogger and Curmudgeon Mark Herrmann recently published "Making Class Actions Work: The Untapped Potential of the Internet" in the Pittsburgh Law Review. [read post]
20 Jan 2009, 11:29 am
: Chicago attorney Mark Herrmann's posted a discussion topic last week on blogging as a tool for business development, referencing a Drug and Device Law blog post on the same. [read post]
12 Jan 2009, 2:28 pm
Blogging for Business Development: Chicago attorney Mark Herrmann asks for feedback on his blog post about blogging as a tool for developing legal business. [read post]
5 Jan 2009, 9:00 pm
(Isn't it nice to get a break from Beck and Herrmann every once in a while, and to hear instead from the folks who wear the robes?) [read post]
29 Dec 2008, 5:00 am
This work is entirely Pearson's; neither Beck nor Herrmann had anything to do with it:The belief that polar bears cover their black noses with a paw to camouflage themselves in the snow and ice while hunting has been generally discredited. [read post]
17 Dec 2008, 10:02 pm
The Fucas agreed with PTC, and they got Jones Day (and partner Mark Herrmann, co-author of the Drug and Device Law blog) to write an amicus brief explaining why the family of one boy with Duchenne would side against the family of another. [read post]
1 Dec 2008, 10:00 pm
Seasoned defense lawyers Jim Beck of Philadelphia and Mark Herrmann of Chicago, along with authoritative guest contributors, pick apart rulings and explore issues common to this niche practice.Those guys have stiff competition when you see the niche category with 15 entrants -- tough competition because they want people to vote. [read post]
1 Dec 2008, 4:14 pm
Drug and Device Law The Drug and Device Law blog is a joint project between two lawyers: Jim Beck and Mark Herrmann. [read post]
11 Nov 2008, 1:00 pm
' The punch line, of course: 'Cases check in, but they never check out.'" Mark Herrmann, "To MDL or Not to MDL? [read post]
10 Nov 2008, 11:20 am
According to an on-line story that appeared today in LAW.COM, Product liability attorneys Mark Herrmann (Jones Day in Chicago) and James Beck (Dechert in Philadelphia) responded quickly by stating that the ruling “stands product liability law on its head. [read post]
1 Nov 2008, 6:11 pm
It's the day after Halloween, but Mark Herrmann's punny little Halloween-Daubert post is still midly amusing. [read post]
13 Oct 2008, 5:12 pm
If you want to keep up with what's happening in federal preemption jurisprudence, the best place is the Drug and Device Law blog of Jim Beck (Deckert LLP, Philadelphia) and Mark Herrmann (Jones Day, Chicago). [read post]
2 Oct 2008, 2:28 pm
For a description of the background of the problem, see Mark Herrmann, "Ohio's Missing En Banc Procedure," Cleveland Bar Journal 6 (Oct. 2003).The Ohio Supreme Court addressed that issue this morning. [read post]
2 Oct 2008, 1:41 pm
., Mark Herrmann, and Geoffrey J. [read post]
25 Sep 2008, 2:42 pm
Now there are more, as detailed in Mark Herrmann's recent post at Drug and Device Law, "A Multidistrict Litigation Compendium. [read post]
23 Sep 2008, 12:00 pm
Courtesy of Mark Herrmann on his Drug and Device Law blog, here is an excellent summary and commentary on the new Federal Rule of Evidence 502 that was signed into law by the President a few days ago, and even has application in some manner to state court cases. [read post]
11 Sep 2008, 8:12 pm
But Herrmann won that issue when it first arose in the Ohio state court system, and Bexis got cited by the U.S. [read post]
10 Sep 2008, 2:30 pm
It doesn't quite cover his teams, but how far wrong can you go with a blog written by a guy named Mark Herrmann? [read post]
1 Sep 2008, 4:03 pm
Mark Herrmann gets to say “I told you so” to the Volokhs when a terminally ill plaintiff succeeded in getting a judge to issue an injunction ordering a drug company to provide him with an unapproved, experimental drug. [read post]
